Rui Lu

16PUBLICATIONS
89CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 02, 2025
MDS-associated SF3B1 mutations promote aberrant fate choice of hematopoietic stem cell via mis-splicing of mediator kinase module component CDK8.

Elizabeth A Bonner, Tun-Yun Hsueh, Axia Song

|Aug 06, 2025
Activation of a nongenetic AHR-ELMSAN1 axis optimizes BET-targeting therapy and suppresses leukemia stem cells in preclinical models.

Xinyue Zhou, Steven Moreira, Cecilia Restelli

|Feb 12, 2025
PTP Inhibition Improves the Macrophage Antitumor Immune Response and the Efficacy of Chemo- and Radiotherapy.

Nestor Prieto-Dominguez, Paran Goel, Oluwagbemiga A Ojo

Pageof 3